## ASML: ASML Holding N.V. - New York Re - XLK: Technology

### Executive Summary

No thesis match: MRS_20 1.6% below STRENGTH zone (4.0-10.0%); PEG 2.12 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1017.19)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. ASML Stock Slips Despite CEO’s Confidence In EUV, Long-Term AI Demand - ASML Holding (NASDAQ:ASML)**
- Source: Benzinga | 20251212T190841 | Somewhat-Bearish | Relevance: 100%
- ASML Holding stock experienced a dip despite CEO Christophe Fouquet's strong confidence in Extreme Ultraviolet (EUV) lithography and the long-term demand for AI. Fouquet emphasized ASML's focus on resolution, accuracy, and productivity, indicating a clear roadmap for the next 10-15 years in lithography and a push into advanced 3D packaging. He also dismissed concerns of an AI bubble, seeing industrial AI as a durable opportunity that will eventually translate into equipment orders, while acknowledging potential future market consolidation.

**2. ASML Holding NV (0QB8): New Buy Recommendation for This Technology Giant**
- Source: The Globe and Mail | 20251212T100841 | Bullish | Relevance: 100%
- UBS analyst Francois Xavier Bouvignies maintained a Buy rating on ASML Holding NV with a price target of €1,030.00. This follows another Buy rating from Citi, while Barclays maintained a Hold rating. ASML Holding NV currently has a market cap of €364B and a P/E ratio of 39.32.

**3. ASML Earns “Top Pick” Status From BofA, Citi Reaffirms Buy Rating**
- Source: Insider Monkey | 20251212T100400 | Somewhat-Bullish | Relevance: 100%
- Bank of America has named ASML Holding N.V. a "Top Pick" and a "Top Idea" for 2026, anticipating a re-rating of the stock based on its 20.6x '27 EV/EBITDA valuation. Citi also reaffirmed a "Buy" rating with a €1,200.00 price target, citing AI-driven demand and positive estimate revision momentum. Despite positive analyst outlooks, geopolitical concerns have emerged regarding ASML's sales of parts to a firm linked to the Chinese military.

**4. ASML Stock Price Forecast - ASML at $1,104: EUV Monopoly and AI Boom vs. 39x Earnings Valuation**
- Source: TradingNEWS | 20251211T171018 | Somewhat-Bullish | Relevance: 100%
- ASML Holding NV maintains its position as a long-term AI lithography heavyweight, benefiting from its monopoly in Extreme Ultraviolet (EUV) lithography critical for AI chip manufacturing. Despite cyclical demand, ASML's robust financial performance, including a 29-30% net income margin and solid order book, supports its growth trajectory towards €44B–€60B in revenue by 2030. However, the stock's current valuation at 39x forward earnings suggests limited short-term upside, leading to a "Hold" recommendation for new entries above $1,050.

**5. Marex Group plc Purchases Shares of 2,417 ASML Holding N.V. $ASML**
- Source: MarketBeat | 20251214T120924 | Bullish | Relevance: 100%
- Marex Group plc initiated a new position in ASML Holding N.V. (NASDAQ:ASML) during the second quarter, acquiring 2,417 shares valued at approximately $1.94 million. ASML has a "Moderate Buy" consensus rating from analysts with a target price of $1,171.83, and its financial performance shows solid earnings and revenue, alongside a recently increased quarterly dividend. The company, a key player in semiconductor equipment, has seen significant institutional interest and positive analyst upgrades.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-03 | B of A Securiti | $1331 | $1092 | +22% |
| 2025-12-01 | JP Morgan | $1275 | $1175 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-03 | B of A Securiti | main | Buy |
| 2025-12-01 | JP Morgan | main | Overweight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 8.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- JPMORGAN CHASE & CO: 1.5% (+170.0%)
- Fisher Asset Managem: 1.1% (+2.5%)
- Capital World Invest: 1.1% (-4.1%)
- Capital Internationa: 1.0% (+17.3%)
- State Farm Mutual Au: 0.7% (0.0%)

### Key Risks

1. Premium valuation (P/E 42x, PEG 2.1x) vulnerable to multiple compression.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.12 elevated, pricing in significant growth expectations. Forward P/E 41.7x stretched relative to 5% growth. Quality metrics strong (ROE 54%, ROA 16%, margin 29%). Analyst sentiment positive (2 raises, avg +15%). Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $419.5B |
| Beta | 1.35 |
| 52W Range | $578.51 - $1141.72 |
| Short Interest | 0.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.12 |
| Forward P/E | 41.7 |
| Current P/E | 43.7 |
| YoY Growth | 4.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 5.1% to 1.6% (-3.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.4pp (needs >4.0% for momentum thesis). MRS_5 (-1.4%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.38), confirming momentum. RSI neutral at 53. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.60% (CS: 51) | Neutral |
| RSI_14 | 53.1 | Neutral |
| MACD Histogram | 2.38 | Bullish |
| vs SMA20 | 1.019x | Above |
| vs SMA50 | 1.039x | Above |
| vs SMA200 | 1.314x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1080.85
- **Stop Loss:** $1017.19 (5.9% risk)
- **Target:** $1144.51 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 15
- **Position Value:** $16,212.75
- **Portfolio %:** 16.21%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-01-28 (Est: $7.53)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.37 | $5.49 | +2.1% |
| 2025Q2 | $5.25 | $5.90 | +12.4% |
| 2025Q1 | $5.79 | $6.00 | +3.7% |
| 2024Q4 | $6.73 | $6.84 | +1.6% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*